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Abstracts
Differences in Outcome in Patients Receiving General and Regional Anesthesia for
Orthopedic Surgery. P.G. Atanassoff, M. Hartmannsgruber and S.J. Brull.
Department of Anesthesiology, Yale University School of Medicine, New Haven,
Connecticut.
Introduction: There is controversy regarding the clinical effectiveness ofpre-emptive
analgesia. In some of the studies, which were unable to demonstrate beneficial effects of
epidural anesthesia (EA) overgeneral anesthesia (GA), the timing and/orduration ofneur-
al blockade may have been inadequate to prevent the postoperative development of
peripheral and central sensitization. The present study sought to determine whether prein-
cisional EA, continued in the post-operative period, would improve the quality of post-
operative analgesia and result in improved outcome.
Methods: Thirty-five ASA class I-HI patients scheduled for hip or knee replacement
or revision gave their informed consent to participate in this IRB approved protocol.
Eleven patients received EA, 12 patients received GA, and, further, 12 patients received
GA+EA. The intra- and postoperative blood loss, level ofconsciousness at recovery room
(PACU) discharge, incidence and severity ofnausea and vomiting (N/V) in the PACU and
on the ward, visual analogue scale (VAS) scores for pain upon PACU discharge, on post-
operative days 1-3 and at hospital discharge, as well as length of hospitalization, were
recorded. Consciousness was rated on a 4-point scale: 1: fully alert; 2: awake but drowsy;
3: asleep but arousable, and 4: unarousable. Data are expressed as mean + SEM and were
analyzed using Fisher's exact test (ANOVA), where p < .05 was considered significant.
Results: There was no statistically significant difference between the three groups
with respect to demographics, incidence of N/V or length of hospital stay. In the EA
group, the blood loss (1037 + 122 ml) was lower than in the GA + EA group (1251 + 169
ml) and GA group (1362 + 257ml), although this difference did not reach statistical dif-
ference. There were, however, significant differences in the patients' level of conscious-
ness at PACU discharge and in the VAS pain scores. Patients who received EA had seda-
tion scores of 1.1 + 0.1 while GA patients scores were 2.2 + 0.2 (p = .0012). Sedation
scores of EA+GA patients (1.5 + 0.2) reached borderline statistical significance (p =
.0536) when compared to GA patients. VAS pain scores in the GA group were signifi-
cantly higher than those in the EA and EA + GA groups at PACU discharge (66 + 7 vs.
10 + 8 and 9 + 4, respectively), on post-operative days 1-3 (39 + 2 vs. 16 + 3 and 16 + 3,
respectively), and at hospital discharge (10 + 4 vs. 1 + 1 and 2 + 1, respectively).
Discussion: We could not confirm previous results of a substantial decrease in blood
loss in patients receiving EA [1]; this may be due to the relatively low number ofpatients
investigated in this pilot study. However, EA alone or in addition to GA appears to be
superior to GA alone for providing perioperative analgesia while allowing patients more
rapid recovery to full consciousness. In surgical procedures associated with high postop-
erative analgesic requirements, EA provided a beneficial pre-emptive analgesic effect,
which outlasted the anticipated duration ofneural blockade.
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General Anesthesia vs. Epidural Anesthesia with Ropivacaine 0.2 Percent for Total
Knee Replacement. P.G. Atanassoff, A. Otellin, Y. Printsev. Department of
Anesthesiology, Yale University School ofMedicine, New Haven Connecticut.
Introduction: Despite great recent advances in the therapeutic management of surgi-
cal patients, postoperative analgesia remains one ofthe most difficult challenges in clini-
cal practice. The present study compared the analgesic efficacy ofepidural ropivacaine to
PCA morphine after total knee replacement. The effect of combining the two treatment
modalities was also evaluated.
Methods: Following HIC approval and informed consent, 96 patients participated in
this multicenter, randomized, prospective study. Groups 1 and 2 received an epidural anes-
thetic (EA) with ropivacaine 1 percent for surgery. Postoperatively, EA was continued for
24 hr with ropivacaine 0.2 percent at 6 ml/hr infusion rate (group 1) or ropivacaine 0.2
percent 6 ml/hr plus PCA morphine (group 2). Patients in group 3 received general anes-
thesia (GA) followed by PCA morphine. Pain scores were evaluated at rest and during
physiotherapy (CPM machine) on a visual analogue scale (VAS) from 0 (no pain) to 100
(worst imaginable pain). Data (mean + SD) were analyzed using the stratified Wilcoxon
rank test and Bonferroni correction to compare treatment groups pairwise; p < .05 was
considered statistically significant.
Results: Patient demographics were similar among the three groups. Postoperatively,
the total infusion dose ofropivacaine 0.2 percent was 183 + 70 ml (group 1) and 168 + 59
ml (group 2). Total top-up doses were 17 + 9 ml and 13 + 10 ml in groups 1 and 2. The
total PCA morphine amount used by groups 2 and 3 during 24 hr postoperatively was 27
+ 20 mg and 55 + 22 mg, respectively. During this time period, the frequency of PCA
attempts resulting in drug delivery in these two groups was 26 + 18 and 55 + 23 times; the
frequency ofPCA attempts that did not result in drug delivery was 35 + 44 and 63 + 50
times. Total morphine consumption in the three groups, which included additional anal-
gesic upon request, was 33 + 45 mg, 41 + 31 mg and 82 + 41 mg, respectively (p < .05
group 1 vs. 3 and 2 vs. 3). Wound pain at rest (p < .05 vs. groups 1 and 2) and with mobi-
lization was consistently higher in group 3 than in groups 1 and 2. Postoperatively, the
highest VAS scores at rest in group 3 were 50 + 26 in contrast to 12 + 14 and 16 + 16 in
groups 1 and 2. Wound pain was also highest in group 3 after physiotherapy (VAS of 39
+ 25 in group 3 vs. 25 + 27 and 22 + 22 in groups 1 and 2, respectively).
Discussion: Knee surgery is a highly painful surgical procedure requiring profound
intraoperative analgesia and motor block. After surgery, mobilization and physiotherapy
are used routinely requiring profound analgesia without motor block. VAS scores during
rest and mobilization were consistently higher in the group ofpatients receiving general
anesthesia. Overall, attempts formorphine delivery as well as morphine consumption was
alsohigher in the general anesthesia group. We conclude that knee replacementperformed
under epidural anesthesia with ropivacaine is associated with better postoperative analge-
sia and is likely to contribute to significantly better recovery, discharge, and patient satis-
faction.
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Heparin-Coated CPB Surgery: Current Clinical Experiences and Controversies.
Branko M. Weiss. Department of Anesthesiology, University Hospital, Zurich,
Switzerland.
Systemic inflammatory response to CPB was evaluated in Oslo, Uppsala, Groningen,
Amsterdam and New York (1992-1997), using ionic-bound (Duraflo 11) or covalent-
bound (Carmeda) type of heparin-coating, and different protocols of systemic hepariniza-
tion (100-400 IU/kg for ACT >200 to >480 sec). Lower complement activation, reduced
leucocyte degranulation and enzyme release, and lower level ofcirculating cytokines were
found with heparin-coated materials, compared to conventional CPB circuit. Complement
activation was found to be heparin dose-independent while low-dose heparinization
decreased granulocyte activation. Minimal differences were found between the two types
of heparin coating.
Descending thoracic aortic surgery was performed with a left heart-bypass or partial
CPB and low dose heparinization (ACT >180 sec) in a series of patients in Zurich (1992-
1994). Compared to a simple clamping, assisted circulation allowed a longer duration and
more extensive aortic repair. Transfusion requirements were not different, but use of
assisted circulation simplified the management, improved the gas exchange during one
lung-ventilation, caused less bleeding requiring revision, and resulted in less complica-
tions and mortality. Reduced systemic heparinization was prospectively compared with
standard heparinization (heparin 100 IU/kg vs. 300 IU/kg, ACT >180 vs. >480 sec) for
heparin-coated CPB in Zurich (1992-1996). Cell-saving device was used in the low-
heparin group. Blood stagnation in the circuit (if required) was prevented by continuous
paracorporeal flow. CPB circuit performance, oxygen data, and indices of anticoagulation
and fibrinolytic activation were similar in both groups. Reduced protamine requirements,
lower chest drainage and homologous transfusion, and less bleeding requiring revision
were found after low-dose heparin. In Oslo (1995-1996), low and standard (ACT >250 vs.
>480 sec) heparin management and coated circuit were compared with standard heparin
dose and uncoated circuit. Thrombin formation and fibrinolysis similarly increased after
reperfusion, at the end ofand after CPB. Lower amount ofheparin was considered accept-
able for anticoagulation during CPB. Autologous blood removal and mild hypothermia
(320C) were used, and the outcome (low mediastinal drainage, short period of postopera-
tive intubation and no myocardial infarction or mortality) was similar in all three groups.
In Boston (1996), normothermic (340C) perfusion, centrifugal pump, minimal cardiotomy
suction, cell-saving device and infusion of EACA were combined in 234 patients under-
going primary CABG. Coated CPB and reduced (ACT >280) heparin dose (vs. uncoated
circuit and ACT >480) resulted in lower chest drainage and transfusion requirements, less
frequent inotropic therapy, shorter ventilatory support, faster recovery, shortened ICU and
hospital stay, and substantially decreased hospital costs. Similar advantages were found in
valve surgery, and 2/120 patients required early reoperation due to valve thrombosis.
Conventional systemic anticoagulation was recommended for valve surgery. Two
Japanese studies (1996) reported advantages of low heparinization with heparin-coated
materials. In Helsinki (1997), heparin 100 IU/kg and coated circuit were prospectively
compared with 300 IU/kg and uncoated perfusion (ACT >200 vs. >480 sec). Blood loss
was significantly lower, but higher prothrombin fragments and D-dimers, and two post-
operative strokes among 15 patients managed with low heparin raised the question of
inadequate anticoagulation with this technique.
Standard systemic heparinization was used in Oslo, Uppsala, Groningen, Pittsburgh
and Amsterdam (1992-1995). No relevant differences in markers of coagulation response
and no or only moderate differences in blood loss were found after heparin-coated vs.
standard CPB circuit. The Pittsburgh group (1994) suggested that platelet activation
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occurs primarily as a result of blood contact with foreign materials, while thrombin gen-
eration and fibrinolytic activity result from reperfusion injury, rewarming and increased
cardiotomy suction. In Philadelphia (1996), coated materials did not produce a meaning-
ful anticoagulant effect, thus lower heparin dosage was not recommended for clinical
CPB. As no influence on coagulability could be expected from coated materials, a low-
dose heparin management was called unwise and dangerous (Edegem). In Cleveland
(1996) no difference in biochemical and clinical markers of biocompatibility was found
between heparin-coated and conventional circuit in reoperative CABG and valvular
surgery. Preliminary data from Seattle (1996) indicated that heparin-coated CPB may
reduce fibrinolytic activation, independent of thrombin formation. A Creteil-Amsterdam
study (1997) suggested that use of both heparin-coated circuit and aprotinin is required to
achieve maximal reduction of blood activation during CPB.
Conclusions: Heparin-coated materials attenuate the bioincompatibility of CPB per-
fusion. Its use allows a reduction of systemic heparinization and may improve the clinical
outcome. Potential clinical risks must be anticipated. Selection of patients and additional
measures are required before routine application of this technique. If standard heparin
management is used, cardiac surgery with heparin-coated or conventional CPB circuit
may not result in relevant outcome differences. Nevertheless, according to the multicen-
tric analysis of European CABG studies (1997), a subgroup of patients (females, longer
aortic cross-clamping time) may profit if heparin-coated circuit is used. Further research
in biomaterials, coagulation and overall body response to CPB are required to raise the
safety and improve the outcome of patients undergoing cardiac surgery.
The Effect of Acute Normovolemic Hemodilution on Vital Signs in a Surgical
Population. Aryeh Shander, Teekam Ochani, and Sherri Ozawa. Englewood Hospital
and Medical Center, Englewood, New Jersey.
Introduction: Acute Normovolemic Hemodilution is advocated as an effective
method of minimizing or eliminating the necessity of homologous blood in the surgical
patient [1]. This study evaluated the effect upon systolic and diastolic blood pressure and
heart rate of decreased RBC concentration from the induced acute anemia of ANH, uti-
lizing current volume replacement to achieve euvolemia.
Methods: We retrospectively reviewed1I18 patients who had ANH performed by dif-
ferent anesthesiologists. The patients (5 children,1I13 adults) underwent a variety ofmajor
surgical procedures, including orthopedic, gynecological, vascular and neurosurgical.
They ranged in age from 2 to 80 years of age. 49.2 percent could not receive blood based
on religious objections. Forty-six of the patients were male and 72 were female. ASA sta-
tus distribution of the patients was as follows: 18 were ASAI; 72 were ASA II; 26 were
ASAIII; and 2 were ASA IV. ANH was performed on all patients: 39 had1 unit of autol-
ogous blood removed; 67 had 2 units removed; 10 had 3 units removed and 2 patients had
4 units removed. Volume was replaced with Hetastarch and Normosol. Blood Pressure and
heart rate measurements used for this study were those recorded at 15-minute intervals
following each ANH unit removed.
Results: The patients pre-ANH hemoglobin measurements ranged from 8.9-16.5 gm
percent. Their immediate post-removal hemoglobins ranged from 7.2-14.0 gm percent.
The average absolute change in heart rate was 6.2 beats per minute; change in systolic
blood pressure 17.9 mm Hg and change in diastolic blood pressure was 10.62 mm Hg.
None of these patients had any cardiorespiratory complications during the perioperative
period.
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Conclusions: We conclude that changes in blood pressure (systolic/diastolic) and
heart rate during and immediately following ANH do not appear to correlate with post
ANH Hb levels. In addition, the change in systolic blood pressure andheart rate were clin-
ically insignificant. Although change in diastolic blood pressure was slightly greater than
20 percent, no significant clinical manifestations were noted, and no cardiopulmonary
complications occurred.
Ahemoglobin level ofless than 10mg/dl were well tolerated irrespective ofASA sta-
tusor age in the group ofpatients.
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Prevention ofSpinal Anaesthesia Induced Hypotension in the Elderly: Vasopressors
or Crystalloid-colloid Prehydration? D. Buggy, C. Power, C. Moran, R. Meeke, F.
O'Donovan, R. O'Brien and M. McCarroll. Departments ofAnaesthesia, Cappagh
Orthopaedic Hospital, Dublin and Cork University Hospital, Cork, Ireland.
Background: The optimum preventive management of spinal anaesthesia-induced
hypotension remains controversial. Investigation in the obstetric population suggests that
prehydration with a 6 percent hetastarch-crystalloid combination may be more effective
than large volume crystalloid prehydration alone [1], which may be harmful. The elderly
have received much less attention in this regard, despite being more vulnerable to hemo-
dynamic embarrassment from fluid infusion and spinal anaesthesia. An infusion of
metaraminol, an alpha-adrenergic agonist, was superior to ephedrine and colloid infusion
in a small elderly group [2]. methoxamine is also an alpha-agonist that may be given intra-
muscularly (IM), avoiding the expense and inconvenience of an infusion pump.
Objectives: To compare the incidence andfrequency ofhypotension andrequirement
for rescue vasopressor therapy following spinal anaesthesia in an elderly population with
(1) crystalloid, colloid or no prehydration; (2) prehydration with combined 6 percent het-
astarch-crystalloid; and (3) Methoxamine 10 mg IM given 10 minutes before induction of
spinal anaesthesia. .
Methods: All patients recruited (age range 60-97 years) were undergoing spinal
anaesthesia for hip surgery with 12.5-15 mg heavy bupivacaine in the lateral position. In
the first study, 85 ASA 1 or 2 patients were randomized to receive 500 ml crystalloid solu-
tion (Group CY, n = 29), 500 ml colloid (HaemacceTM, Group CD, n = 28) or "keep vein
open" (50 ml/hr, Group KVO, n = 28) over 10 minutes prior to the induction of spinal
anaestheia. A second study investigated prehydration with combined 6 percent hetastarch
(HespanTM) 500 ml and crystalloid 500 ml (Group HS, n = 32) with methoxamine 10 mg
IM given 10 minutes before induction of spinal anaesthesia (Group MX, n = 30). Blood
pressure was measured non-invasively by oscillotonometry at 2 min intervals for 10 min
before induction of spinal anaesthesia and up to 60 min thereafter. Hypotension was
defined as 25 percent decrease frombaseline systolic arterial pressure (SAP) ormean arte-
rial pressure (MAP) or SAP <90 mmHg, and was treated as required with methoxamine
2 mg or ephedrine 3 mg boluses.
Results: Groups were comparable in terms of physical characteristics, demographic
data, baseline SAP and MAP, sensory level and blood loss. There was a progressive and
significant decrease in SAP and MAP in all groups, but values were significantly higher
in MX compared with HS (p < .05) and in CD compared with CY and KVO, p < .01).
Heart rate was lower in MX than all other groups at all times (p < .001). Incidence ofSAP602 Abstracts
hypotension (but not of MAP hypotension) and requirement for and dose of vasopressor
therapy was less in MX compared with HS (p < 0.05). However KVO was similar to CD
and CY in terms of incidence ofhypotension and vasopressor use.
Conclusions: IM methoxamine 10 mg 10 min before induction ofspinal anaesthesia
reduces subsequent SAP hypotension, HR and requirement for rescue vasopressor thera-
py. Withholding prehydration was not associated with any greater reduction in SAP or
MAP or need for vasopressor therapy compared to a crystalloid or colloid prehydration
alone. The reported benefit ofprehydration with combined 6 percent hetastarch and crys-
talloid in parturients was not demonstrable in this elderly population. Routine large-vol-
ume prehydration ofelderly patients for spinal anaesthesia is not justified.
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Tramadol: A Clinical Profile. G.C. Fenn, Searle, Ireland.
Although relatively recently licensed in Ireland, tramadol has been used in clinical
practice in other European countries for two decades, and has been prescribed to over 45
million patients. The clinical profile of the oral and parenteral formulations is therefore
very well defined in terms ofboth efficacy and safety.
Tramadol's two enantiomers produce analgesia by combining weak opioid and
monoaminergically mediated mechanisms, with evidence suggestive of synergy, It is
rapidly and completely absorbed, with high oral bioavailability and a relatively long plas-
ma half-life.
It has been used by the IV and PCA routes in many post-operative pain studies [1].
An IV. study in moderate to severe pain following abdominal surgery showed equivalent
analgesic efficacy to morphine [2]. Recent data confirm its efficacy and safety when used
as a combined intra- and post-operative analgesic in day case surgery [3]. This and two
other recent studies incorporating contemporary anaesthetic methods indicate that intra-
operative use oftramadol is safe and not accompanied by lightening of anaesthesia [4] .
Oral tramadol has been assessed in the single and multiple dose situation. A single-
patient meta-analysis of3453 post-operative patients has shown its efficacy in post-surgi-
cal and post-dental extraction pain [5]. Number-needed-to-treat values for tramadol 75
mg-150 mg were superiorto codeine 60 mg and in a very acceptable range similarto com-
parator combination products (aspirin/codeine; acetaminophen/propoxyphene). Adverse
events (headache, nausea, vomiting, dizziness, somnolence) had a similar incidence to
comparator drugs.
Oral tramadol has also been found to be useful for cancerrelatedpain, with the added
benefit of a reduction in constipation compared to morphine [6].
Tramadol differs from standard opioids in that it produces less respiratory depression
and is associated with lower rates oftolerance, dependence [7], constipation and sedation
[8].
The combination of good efficacy in a wide range of clinical conditions and a low
potential for serious side effects provide tramadol with a useful profile both for short and
long-term use in hospital and the community.
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